排序方式: 共有74条查询结果,搜索用时 296 毫秒
31.
32.
33.
34.
35.
Hassan M Hasan S Giday S Alamgir L Banks A Frederick W Smoot D Castro O 《Journal of the National Medical Association》2003,95(10):939-942
PURPOSE: To determine the prevalence of hepatitis C virus antibodies (anti-HCV) in patients with sickle cell disease. PATIENTS AND METHODS: Between 1983 and 2001, 150 patients from the Howard University Hospital Center for Sickle Cell Disease were screened for HCV antibody (52% women, 48% men, mean age 34 years). Frozen serum samples from 56 adult sickle cell patients who had participated in previous surveys (1983-92) of HIV and HTLV-1 serology and who were tested in 1992 for anti-HCV antibody--when commercial ELISA test (Ortho) became available--were included in this paper. Of the 150 patients in the study, 132 had sickle cell anemia genotype (SS), 15 had sickle cell hemoglobin-C disease (SC) and three had sickle beta thalassemia. Clinical charts were reviewed for history of blood transfusion, IV drug abuse, homosexuality, tattooing, iron overload, and alcohol abuse. RESULTS: Antibodies to HCV were detected in 53 patients (35.3%). Of the 55 patients who had frozen serum samples tested in 1992, 32 (58%) were reactive for anti-HCV, while only 21 of the 95 patients (22%) tested after 1992 were positive for HCV antibodies (P<0.001). Thirty-nine of 77 patients (51%) who received more than 10 units of packed red blood cells were positive for HCV antibody, and only 14 of 61 patients (23%) who received less than 10 units of packed red blood cells transfusion were positive for HCV antibodies (P<0.001). None of the 12 patients who never received transfusion were positive for HCV antibody. In the 53 anti-HCV positive patients, the mean alanine amino-transferase (ALT) value was 98- and 81 U/L, respectively, for males and females. These values were normal for the HCV-antibody negative patients. The aspartate amino-transferase (AST) and the total bilirubin were also higher in the anti-HCV positive patients compared to patients in the anti-HCV negative group. Forty-four patients (57.1%) who were transfused more than 10 units developed iron overload defined by a serum ferritin level higher than 1,000 ng/ml. A total of 20 of the patients with iron overload underwent liver biopsies. Seven of these 20 patients (35%) were HCV positive. These patients often had more severe liver disease and higher degree of iron deposition. CONCLUSION: The prevalence of HCV antibody and iron overload is directly related to the number of blood transfusions in patients with sickle cell disease. The prevalence of HCV infection has decreased significantly, since blood donor screening for HCV became available. Chronic HCV infection and iron overload place sickle cell patients at risk for significant liver disease. 相似文献
36.
37.
Magno P Giday SA Gabrielson KL Shin EJ Buscaglia JM Clarke JO Ko CW Jagannath SB Canto MI Sedrakyan G Kantsevoy SV 《Gastrointestinal endoscopy》2007,66(2):387-392
BACKGROUND: EUS is the preferred modality for local staging of esophageal cancer. The presence of a long-lasting fluoroscopically visible marker of malignant lymph nodes would facilitate subsequent radiation and surgical therapy. OBJECTIVE: To assess the feasibility of EUS-guided implantation of a radiopaque marker (tantalum) into mediastinal and celiac lymph nodes in a porcine model. SETTING: Survival experiments on six 50-kg pigs. DESIGN AND INTERVENTIONS: A linear-array echoendoscope was advanced into the esophagus and the stomach. Mediastinal and celiac lymph nodes were identified and injected with 1 mL tantalum suspension by using 19- and 22-gauge FNA needles under fluoroscopy. The pigs were recovered. Fluoroscopy was repeated after 1, 2, and 4 weeks, then a postmortem examination was performed. MAIN OUTCOME MEASUREMENTS: Long-term opacification of lymph nodes. RESULTS: It was not possible to inject tantalum through the 22-gauge FNA needle because of its rapid precipitation inside the needle, which caused needle occlusion. Intranodal injection with the 19-gauge FNA needle was easily accomplished and resulted in excellent fluoroscopic opacification of injected lymph nodes. Repeat fluoroscopy at 1, 2, and 4 weeks demonstrated stable tantalum deposition at the injection site. There were no complications. Histologic examination of harvested lymph nodes revealed intranodal tantalum depositions without signs of infection, inflammation, tissue damage, or necrosis. CONCLUSIONS: EUS-guided implantation of tantalum as a radiopaque marker into mediastinal and celiac lymph nodes in a porcine model is technically feasible, safe, and results in long-lasting intranodal depositions to facilitate subsequent surgical and radiotherapeutic interventions. 相似文献
38.
Meireles O Kantsevoy SV Kalloo AN Jagannath SB Giday SA Magno P Shih SP Hanly EJ Ko CW Beitler DM Marohn MR 《Surgical endoscopy》2007,21(6):998-1001
Background The peroral transgastric endoscopic approach for intraabdominal procedures appears to be feasible, although multiple aspects
of this approach remain unclear. This study aimed to measure intraperitoneal pressure in a porcine model during the peroral
transgastric endoscopic approach, comparing an endoscopic on-demand insufflator/light source with a standard autoregulated
laparoscopic insufflator.
Methods All experiments were performed with 50-kg female pigs under general anesthesia. A standard upper endoscope was advanced perorally
through a gastric wall incision into the peritoneal cavity. The peritoneal cavity was insufflated with operating room air
from an endoscopic light source/insufflator. Intraperitoneal pressure was measured by three routes: (1) through the endoscope
biopsy channel, (2) through a 5-mm transabdominal laparoscopic port, and (3) through a 16-gauge Veress needle inserted into
the peritoneal cavity through the anterior abdominal wall. The source of insufflation alternated between on-demand manual
insufflation through the endoscopic light source/insufflator using room air and a standard autoregulated laparoscopic insufflator
using carbon dioxide (CO2).
Results Six acute experiments were performed. Intraperitoneal pressure measurements showed good correlation regardless of measurement
route and were independent of the type of insufflation gas, whether room air or CO2. On-demand insufflation with the endoscopic light source/insufflator resulted in a wide variation in pressures (range, 4–32
mmHg; mean, 16.0 ± 11.7). Intraabdominal pressures using a standard autoregulated laparoscopic insufflator demonstrated minimal
fluctuation (range, 8–15 mmHg; mean, 11.0 ± 2.2 mmHg) around a predetermined value.
Conclusion Use of an on-demand unregulated endoscopic light source/insufflator for translumenal surgery can cause large variation in
intraperitoneal pressures and intraabdominal hypertension, leading to the risk of hemodynamic and respiratory compromise.
Safety may favor well-controlled intraabdominal pressures achieved with a standard autoregulated laparoscopic insufflator.
Presented in part at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, April 2006,
Dallas, TX, USA 相似文献
39.
40.